Live Breaking News & Updates on Director Young Kwon

Stay updated with breaking news from Director young kwon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ADMA Biologics (NASDAQ:ADMA) Given "Buy" Rating at HC Wainwright

ADMA Biologics (NASDAQ:ADMA) Given "Buy" Rating at HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Nova Scotia , Kyoung Kwon , Raymond James , Bryant Fong , Securities Exchange Commission , Biologics Inc , Jpmorgan Chase Co , Raymond James Associates , Blackrock Inc , York Mellon Corp , Cantor Fitzgerald , Free Report , Get Free Report , Director Young Kwon , Exchange Commission , Director Bryant Fong , New York Mellon Corp , Montreal Can ,

ADMA Biologics (NASDAQ:ADMA) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of ADMA Biologics (NASDAQ:ADMA – Free Report) from a sell rating to a hold rating in a report published on Saturday morning. Several other analysts have also recently commented on the company. Cantor Fitzgerald raised their target price on ADMA Biologics from $5.00 to $6.00 and gave the company an overweight rating […] ....

United States , Brian Lenz , Kyoung Kwon , Raymond James , Securities Exchange Commission , Biologics Inc , Tucker Asset Management , Cerity Partners , Pricet Rowe Associates Inc , Biologics Company Profile , Envestnet Asset Management Inc , Virtu Financial , Cantor Fitzgerald , Free Report , Get Free Report , Director Young Kwon , Exchange Commission , Asset Management , Adma Biologics , Nasdaq Adma , Stocknews Com ,

ADMA Biologics (NASDAQ:ADMA) Lifted to Hold at StockNews.com

StockNews.com upgraded shares of ADMA Biologics (NASDAQ:ADMA – Free Report) from a sell rating to a hold rating in a research report released on Friday morning. ADMA has been the subject of a number of other reports. HC Wainwright boosted their target price on shares of ADMA Biologics from $4.50 to $5.00 and gave the […] ....

United States , Raymond James , Brian Lenz , Kyoung Kwon , Biologics Inc , Biologics Company Profile , Tucker Asset Management , Cantor Fitzgerald , Cerity Partners , Pricet Rowe Associates Inc , Envestnet Asset Management Inc , Virtu Financial , Free Report , Get Free Report , Director Young Kwon , Asset Management , Adma Biologics , Nasdaq Adma , Stocknews Com ,

ADMA Biologics, Inc. (NASDAQ:ADMA) Director Young Kwon Purchases 25,000 Shares

ADMA Biologics, Inc. (NASDAQ:ADMA – Get Free Report) Director Young Kwon acquired 25,000 shares of ADMA Biologics stock in a transaction on Thursday, August 24th. The shares were bought at an average cost of $3.90 per share, for a total transaction of $97,500.00. Following the completion of the transaction, the director now owns 277,401 shares […] ....

United States , Kyoung Kwon , Connor Clark Lunn Investment Management Ltd , Adma Biologics Inc , Securities Exchange Commission , Biologics Company Profile , Cantor Fitzgerald , Capital Partners , Biologics Inc , Elevate Inc , Get Free Report , Director Young Kwon , Exchange Commission , Stock Down , Lunn Investment Management , Caligan Partners , Adma Biologics , Nasdaq Adma , Insider Trading , Nsider Trades ,